DexCom (DXCM) Misses Q4 EPS by 17c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P dip, trading choppy as tech stocks fall
- Brent hits lowest since before start of Iran war as more tankers exit Hormuz, easing supply
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
DexCom (DXCM) PT Lowered to $553 at Cowen
February 11, 2022 7:26 AM ESTCowen analyst Joshua Jennings lowered the price target on DexCom (NASDAQ: DXCM) to $553.00 (from $655.00) while maintaining an Outperform rating.
The analyst commented, "After releasing its 4Q21 sales results and 2022 revenue guidance last month, DXCM today reported its full 4Q21 results and provided its 2022... More
